Ke Y - Search Results

1

Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma.

Chen Z, Chen Y, Li Y, Lian W, Zheng K, Zhang Y, Zhang Y, Lin C, Liu C, Sun F, Sun X, Wang J, Zhao L, Ke Y. Chen Z, et al. Among authors: ke y. Cell Death Dis. 2021 Jun 15;12(6):615. doi: 10.1038/s41419-021-03882-7. Cell Death Dis. 2021. PMID: 34131109 Free PMC article.

2

Human mesenchymal stem cells-like cells as cellular vehicles for delivery of immunotoxin in vitro.

Hu CC, Ke YQ, Sun XL, Jiang XD, Xu RX, Lv J, Wang YS, Cai YQ, Qin LS, Zou YX. Hu CC, et al. Biotechnol Lett. 2009 Feb;31(2):181-9. doi: 10.1007/s10529-008-9860-9. Epub 2008 Oct 16. Biotechnol Lett. 2009. PMID: 18923908

3

Investigation of a plasmid containing a novel immunotoxin VEGF165-PE38 gene for antiangiogenic therapy in a malignant glioma model.

Hu CC, Ji HM, Chen SL, Zhang HW, Wang BQ, Zhou LY, Zhang ZP, Sun XL, Chen ZZ, Cai YQ, Qin LS, Lu L, Jiang XD, Xu RX, Ke YQ. Hu CC, et al. Int J Cancer. 2010 Nov 1;127(9):2222-9. doi: 10.1002/ijc.25217. Int J Cancer. 2010. PMID: 20127864

4

Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells.

Sun XL, Xu ZM, Ke YQ, Hu CC, Wang SY, Ling GQ, Yan ZJ, Liu YJ, Song ZH, Jiang XD, Xu RX. Sun XL, et al. Cancer Lett. 2011 Dec 22;312(2):168-77. doi: 10.1016/j.canlet.2011.07.035. Epub 2011 Aug 17. Cancer Lett. 2011. PMID: 21924825

5

Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG.

Ling G, Wang S, Song Z, Sun X, Liu Y, Jiang X, Cai Y, Du M, Ke Y. Ling G, et al. Among authors: ke y. Cancer Biol Ther. 2011 Dec 1;12(11):978-88. doi: 10.4161/cbt.12.11.18155. Epub 2011 Dec 1. Cancer Biol Ther. 2011. PMID: 22104964 Free PMC article.

6

Vasculogenic mimicry and its clinical significance in medulloblastoma.

Wang SY, Yu L, Ling GQ, Xiao S, Sun XL, Song ZH, Liu YJ, Jiang XD, Cai YQ, Ke YQ. Wang SY, et al. Cancer Biol Ther. 2012 Mar;13(5):341-8. doi: 10.4161/cbt.19108. Epub 2012 Mar 1. Cancer Biol Ther. 2012. PMID: 22258034 Free article.

7

Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.

Wang SY, Ke YQ, Lu GH, Song ZH, Yu L, Xiao S, Sun XL, Jiang XD, Yang ZL, Hu CC. Wang SY, et al. J Neurooncol. 2013 May;112(3):339-45. doi: 10.1007/s11060-013-1077-7. Epub 2013 Feb 16. J Neurooncol. 2013. PMID: 23417321

8

Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α.

Huang M, Ke Y, Sun X, Yu L, Yang Z, Zhang Y, Du M, Wang J, Liu X, Huang S. Huang M, et al. Among authors: ke y. Oncol Rep. 2014 Nov;32(5):1973-80. doi: 10.3892/or.2014.3454. Epub 2014 Aug 29. Oncol Rep. 2014. PMID: 25175735

9

Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2.

Liang Y, Huang M, Li J, Sun X, Jiang X, Li L, Ke Y. Liang Y, et al. Among authors: ke y. Oncol Lett. 2014 Oct;8(4):1849-1855. doi: 10.3892/ol.2014.2401. Epub 2014 Jul 31. Oncol Lett. 2014. PMID: 25202424 Free PMC article.

10

Krüppel-like factor 9 inhibits glioma cell proliferation and tumorigenicity via downregulation of miR-21.

Huang S, Wang C, Yi Y, Sun X, Luo M, Zhou Z, Li J, Cai Y, Jiang X, Ke Y. Huang S, et al. Among authors: ke y. Cancer Lett. 2015 Jan 28;356(2 Pt B):547-55. doi: 10.1016/j.canlet.2014.10.007. Epub 2014 Oct 8. Cancer Lett. 2015. PMID: 25305446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,292 results

Search Page

Filters